Evidence map›Paper›PMID 24007507›Full record

ArticleAccounts of chemical research2013

Designing mimics of membrane active proteins.

Federica Sgolastra, Brittany M Deronde, Joel M Sarapas, Abhigyan Som, Gregory N Tew

Open access · greenAbstract read
In one paragraph

Article in Accounts of chemical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Sequence segregation improves non-covalent protein delivery.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  18. Article
  19. Article
  20. Anion Recognition as a Supramolecular Switch of Cell Internalization.Journal of the American Chemical Society · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Federica SgolastraDepartment of Polymer Science and Engineering, University of Massachusetts , Amherst, Massachusetts 01003, United States.
Brittany M Deronde
Joel M Sarapas
Abhigyan Som
Gregory N Tew
University of Massachusetts Amherst · US

Funding

Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious DiseaseU01AI082192 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI TEW, GREGORY N. · 2009 to 2013
$7.0M
CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
Design and mechanistic studies of mimics of antimicrobial peptidesR01AI074866 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM · 2008 to 2012
$3.0M
Design and mechanistic studies of mimics of antimicrobial peptidesR56AI074866 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEGRADO, WILLIAM · 2013 to 2013
$573k
NIAID NIH HHS AI-074866NIAID NIH HHS AI-082192NIAID NIH HHS R01 AI074866NIAID NIH HHS U01 AI082192NIGMS NIH HHS T32 GM008515
6 · The paper itself

Abstract

As a semipermeable barrier that controls the flux of biomolecules in and out the cell, the plasma membrane is critical in cell function and survival. Many proteins interact with the plasma membrane and modulate its physiology. Within this large landscape of membrane-active molecules, researchers have focused significant attention on two specific classes of peptides, antimicrobial peptides (AMPs) and cell penetrating peptides (CPPs), because of their unique properties. In this Account, we describe our efforts over the last decade to build and understand synthetic mimics of antimicrobial peptides (SMAMPs). These endeavors represent one specific example of a much larger effort to understand how synthetic molecules interact with and manipulate the plasma membrane. Using both defined molecular weight oligomers and easier to produce, but heterogeneous, polymers, we have generated scaffolds with biological potency exceeding that of the natural analogues. One of these compounds has progressed through a phase II clinical trial for pan-staph infections. Modern biophysical assays have highlighted the interplay between the synthetic scaffold and lipid composition: a negative Gaussian curvature is required both for pore formation and for the initiation of endosome creation. Although work remains to better resolve the complexity of this interplay between lipids, other bilayer components, and the scaffolds, significant new insights have been discovered. These results point to the importance of considering the various aspects of permeation and how these are related to "pore formation". More recently, our efforts have expanded toward protein transduction domains, or mimics of cell penetrating peptides. Using a combination of unique molecular scaffolds and guanidinium-rich side chains, we have produced an array of polymers with robust membrane (and delivery) activity. In this new area, researchers are just beginning to understand the fundamental interactions between these new scaffolds and the plasma membrane. Negative Gaussian curvature is also important in these systems, but the detailed relationships between molecular structure, self-assembly with lipids, and translocation will require more investigation. It has become clear that the combination of molecular design, biophysical models, and biological evaluation provides a robust approach to the generation and study of novel proteinomimetics.

Indexed as

BiomimeticsDrug DesignAntimicrobial Cationic PeptidesMembrane ProteinsMolecular StructureAntimicrobial Cationic PeptidesMembrane Proteins

Identifiers

PMID24007507
PMCPMC4106261
OpenAlexW2314740229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.